Brennan Kevin M. — SEC Form 4 filings
SEC reporting owner CIK 1971303. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-05-03 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,629 shares, $2,948 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 1,803 shares @ $0.98 ($1,774) in Xilio Therapeutics, Inc., filed 2025-01-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | SVP, FINANCE AND ACCOUNTING | 5 | — | 2 legs · 3,629 sh · $2,948 | 15 |
Form 4 filings — Brennan Kevin M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | Xilio Therapeutics, Inc. (XLO) | Option exercise (M): 5,000 · Sale (S): 1,826 @ $0.64 · Grant/award (A): 95,221 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 131,700 (derivative) @ $0 · Disposition to issuer (D): 55,000 (derivative) · Grant/award (A): 55,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · +1 more | EDGAR |
| 2025-01-03 | 4 | Xilio Therapeutics, Inc. (XLO) | Option exercise (M): 5,000 · Sale (S): 1,803 @ $0.98 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1971303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →